— Know what they know.
Not Investment Advice
Also trades as: INDV.L (LSE) · $vol 5M

INDV NASDAQ

Indivior Pharmaceuticals Inc
1W: -1.0% 1M: +12.2% 3M: +10.5% YTD: +4.8% 1Y: +227.4% 3Y: +98.0% 5Y: +263.7%
$37.53
+0.07 (+0.19%)
 
Weekly Expected Move ±5.8%
$33 $35 $37 $39 $41
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Buy · Power 68 · $4.7B mcap · 116M float · 2.27% daily turnover · Short 54% of daily vol

📊 Key Metrics

TTM
$1B
Revenue
+10.2% YoY
$251M
Net Income
+1830.8% YoY
$-185M
Free Cash Flow
-240.6% YoY
87.4%
Gross Margin
43.2%
Op. Margin
28.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-112.6%
ROA19.9%
ROIC548.6%

Valuation

P/E18.7
P/B-32.7
EV/EBITDA10.2

Leverage

Debt/Equity-3.58
Current Ratio0.71
Interest Cov.9.6x

Quality Scores

Piotroski F4/9
Altman Z3.40
Beneish M-1.01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms